Ray Dalio's position in Astrazeneca plc is currently worth $50.8M. That's 0.20% of their equity portfolio (91st largest holding). The first Astrazeneca plc trade was made in Q2 2021. Since then Ray Dalio bought shares eleven more times and sold shares on five occasions. The stake costed the investor $42.4M, netting the investor a gain of 20% so far.